Picton Mahoney Asset Management Makes New $4.61 Million Investment in Translational Development Acquisition Corp. (NASDAQ:TDACU)

Picton Mahoney Asset Management acquired a new position in shares of Translational Development Acquisition Corp. (NASDAQ:TDACUFree Report) during the 4th quarter, Holdings Channel.com reports. The firm acquired 250,000 shares of the company’s stock, valued at approximately $4,610,000.

Several other institutional investors also recently bought and sold shares of the company. Schechter Investment Advisors LLC purchased a new position in Translational Development Acquisition during the 4th quarter worth $2,778,000. Wealthspring Capital LLC purchased a new position in Translational Development Acquisition during the 4th quarter worth $1,095,000. MMCAP International Inc. SPC purchased a new position in Translational Development Acquisition during the 4th quarter worth $6,454,000. Wolverine Asset Management LLC purchased a new position in Translational Development Acquisition during the 4th quarter worth $5,716,000. Finally, Calamos Advisors LLC purchased a new position in Translational Development Acquisition during the 4th quarter worth $6,915,000.

Translational Development Acquisition Stock Performance

TDACU opened at $10.14 on Friday. Translational Development Acquisition Corp. has a 52 week low of $10.00 and a 52 week high of $10.30. The business’s fifty day moving average price is $10.08.

About Translational Development Acquisition

(Free Report)

Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.

See Also

Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACUFree Report).

Institutional Ownership by Quarter for Translational Development Acquisition (NASDAQ:TDACU)

Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.